Variable response to long-term corticosteroid therapy in chronic beryllium disease

Chest

Volumn 126, Issue 6, 2004, Pages 2000-2007

  Sood, Akshay ^a   Beckett, William S ^b   Cullen, Mark R ^c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beryllium; Chronic beryllium disease; Corticosteroids; Sarcoidosis

Indexed keywords

CARBON MONOXIDE; CORTICOSTEROID; PREDNISONE;

ABSCESS; ALCOHOLIC PANCREATITIS; ARTICLE; ASTHMA; BERYLLIOSIS; CLINICAL ARTICLE; COMORBIDITY; CORTICOSTEROID THERAPY; FOLLOW UP; HEPATITIS; HUMAN; HUMAN CELL; LONG TERM CARE; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LYMPHADENITIS; LYMPHOCYTE PROLIFERATION; OCCUPATIONAL EXPOSURE; PARAMETER; PEPTIC ULCER; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS; SCHISTOSOMA; SINUSITIS; THORAX RADIOGRAPHY; THORAX WALL;

EID: 10444246597     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.6.2000     Document Type: Article

References (42)

1. NIOSH. National Occupational Hazard Survey: Volume III; Survey analysis and supplemental tables. Washington, DC: US Government Printing Office, 1977
2. Meeting of the IARC working group on beryllium, cadmium, mercury and exposures in the glass manufacturing industry. Scand J Work Environ Health 1993; 19:360-363
3. Maier LA, Newman LS. Beryllium disease. In: Rom WN, ed. Environmental and occupational medicine. Philadelphia, PA: Lippincott-Raven, 1998; 1017-1035
4. Aronchick JM, Rossman MD, Miller WT. Chronic beryllium disease: diagnosis, radiographic findings, and correlation with pulmonary function tests. Radiology 1987; 163:677-682
5. Andrews JL, Kazemi H, Hardy HL. Patterns of lung dysfunction in chronic beryllium disease. Am Rev Respir Dis 1969; 100:791-800
6. Freiman DG, Hardy HL. Beryllium disease: the relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. beryllium case registry. Hum Pathol 1970; 1:25-44
7. Newman LS. Beryllium disease and sarcoidosis: clinical and laboratory links. Sarcoidosis 1995; 12:7-19
8. Mroz MM, Kreiss K, Lezotte DC, et al. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol 1991; 88:54-60
9. Bobka CA, Stewart LA, Engelken GJ, et al. Comparison of in vivo and in vitro measures of beryllium sensitization. J Occup Environ Med 1997; 39:540-547
10. Curtis GH. Cutaneous hypersensitivity due to beryllium. Arch Syphilol 1951; 64:470-482
11. Newman LS, Kreiss K, King TE Jr, et al. Pathologic and immunologic alterations in early stages of beryllium disease: re-examination of disease definition and natural history. Am Rev Respir Dis 1989; 139:1479-1486
12. Newman LS, Lloyd J, Daniloff E. The natural history of beryllium sensitization and chronic beryllium disease. Environ Health Perspect 1996; 104S:937-943
13. Van Ordstrand HS, Hughes R, Carmody MG. Chemical pneumonia in workers extracting beryllium oxide: report of three cases. Cleve Clin J Med 1943; 10:10-18
14. Kreiss K, Newman LS, Mroz MM, et al. Screening blood test identifies subclinical beryllium disease. J Occup Med 1989; 31:603-608
15. Kreiss K, Mroz MM, Zhen B, et al. Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis 1993; 148:985-991
16. Kolanz ME. Introduction to beryllium: uses, regulatory history, and disease. Appl Occup Environ Hyg 2001; 16:559-567
17. Kreiss K, Wasserman S, Mroz MM, et al. Beryllium disease screening in the ceramics industry: blood lymphocyte test performance and exposure-disease relations. J Occup Med 1993; 35:267-274
18. Deubner DC, Goodman M, Iannuzzi J. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey. Appl Occup Environ Hyg 2001; 16:521-526
19. Maier LA. Beryllium health effects in the era of the beryllium lymphocyte proliferation test. Appl Occup Environ Hyg 2001; 16:514-520
20. Rossman MD. Chronic beryllium disease: diagnosis and management. Environ Health Perspect 1996; 104S:945-947
21. Hasan FM, Kazemi H. Chronic beryllium disease: a continuing epidemiologic hazard. Chest 1974; 65:289-293
22. Cullen MR, Kominsky JR, Rossman MD, et al. Chronic beryllium disease in a precious metal refinery: clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume. Am Rev Respir Dis 1987; 135:201-208
23. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique, 1995 update. Am J Respir Crit Care Med 1995; 152:2185-2198
24. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
25. 3. Am J Ind Med 1996; 30:16-25
26. Newman LS, Bobka C, Schumacher B, et al. Compartmentalized immune response reflects clinical severity of beryllium disease. Am J Respir Crit Care Med 1994; 150:135-142
27. Newman LS, Kreiss K. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium. Am Rev Respir Dis 1992; 145:1212-1214
28. Newman LS. Immunology, genetics, and epidemiology of beryllium disease. Chest 1996; 109:40S-43S
29. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 1993; 262:242-244
30. Richeldi L, Kreiss K, Mroz MM, et al. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am J Ind Med 1997; 32:337-340
31. Stubbs J, Argyris E, Lee CW, et al. Genetic markers in beryllium hypersensitivity [abstract]. Chest 1996; 109:45S
32. Peyton MF, Worcester J. Exposure data and epidemiology of the beryllium case registry-1958. AMA Arch Ind Health 1959; 19:94-99
33. Seeler AO. Treatment of chronic beryllium poisoning. AMA Arch Ind Health 1959; 19:82,164-186,168
34. Hardy HL. The disability found in persons exposed to certain beryllium compounds. AMA Arch Ind Health 1955; 12:174-181
35. Sprince NL, Kanarek DJ, Weber AL, et al. Reversible respiratory disease in beryllium workers. Am Rev Respir Dis 1978; 117:1011-1017
36. Nishikawa S, Hirata T, Kitaichi M, et al. Three years prospective study of Mantoux reactions in factory workers exposed to beryllium oxide. Cardiff, Wales: Alpha Omega Publishing, 1980
37. Stoeckle JD, Hardy HL, Weber AL. Chronic beryllium disease: long-term follow-up of sixty cases and selective review of the literature. Am J Med 1969; 46:545-561
38. Ferris BG. Pulmonary function in patients with beryllium intoxication. AMA Arch Ind Health 1958; 19:147-149
39. Gaensler EA, Verstraeten JM, Weil WB, et al. Respiratory pathophysiology in chronic beryllium disease. AMA Arch Ind Health 1958; 19:50,132-163,146
40. DeNardi JM. Long-term experience with beryllium disease. AMA Arch Ind Health 1958; 19:110-116
41. Eisenbud M, Lisson J. Epidemiological aspects of beryllium-induced nonmalignant lung disease: a 30-year update. J Occup Med 1983; 25:196-202
42. Rossman MD. Differential diagnosis of chronic beryllium disease. Baltimore, MD: Williams & Wiltons, 1991